Firsthand Experience with Fenbendazole, Ivermectin, Lactoferrin?

@cxracer, I encourage you to read the comments shared in this discussion:
- Ivermectin for Prostate Cancer? (Being studied) https://connect.mayoclinic.org/discussion/ivermectin-for-prostate-cancer/

This is what Mayo Clinic experts would like you to know:
- Mayo Clinic on use of ivermectin or other dewormers to treat cancer https://connect.mayoclinic.org/blog/about-connect/newsfeed-post/mayo-clinic-on-use-of-ivermectin-or-other-dewormers-to-treat-cancer/

Important
It is NOT safe to take ivermectin used in veterinary medicine. Please talk to your doctor before taking any over-the-counter medications or supplements that claim to fight or cure cancer.

Where did you hear about fenbendazole, ivermectin, lactoferrin for treatment of cancer? Was this suggested by your oncologist or something you read about?

@colleenyoung this is something that I have read about, in several locations.

@cxracer, I'm not surprised. There's a lot of information as well as misinformation circulating about ivermectin, fenbendazole and other repurposed drugs and their use as a treatment for cancer. These things seem to spread like wild fire on social media claiming cure with wild headlines. These articles get shared and reshared, and soon you find yourself thinking either "there must be something to this." or "maybe I should pay attention. Is this something I should be doing?"

These kinds of articles follow a formula with click-bait titles and other tactics. This is an article that Mayo Clinic wrote to help:
- Can you spot a fake health article? https://www.mayoclinic.org/healthy-lifestyle/consumer-health/in-depth/spot-fake-health-articles-misinformation/art-20587692

You might also appreciate this clear and well-written article about repurposed drugs like the ones you're asking about and the research to date.

- Separating fact from fiction: repurposed drugs in cancer treatment https://www.anticancerfund.org/en/blog/separating-fact-fiction-repurposed-drugs-cancer-treatment

I have read numerous stories online about these miracle cures brought about by these drugs; read many papers about current research on them; and have even been told stories to my face about a friend of a friend who blah, blah…
But I personally have never, ever met a single person who told me directly that he successfully cured his Pca with anti parasitics. Would LOVE to meet one!
I have, however, met and know individuals who used ivermectin during Covid; some recovered from the virus after a few weeks, as most do. Some required hospitalization, as some do; and probably some died, but no one that I personally knew.
Phil

I'm realistically not counting on any oral medication or supplement to cure my prostate cancer, but if any of these three, (FenBen, IVR, Lactoferin), had any real-world results with slowing or fighting prostate cancer, I'd be willing to test drive them. That's why I posed the original question. That's all. Thanks for your responses. After consulting with Mayo, it sounds like RP (surgery) is in my near future.

@colleenyoung Thanks for bringing common sense into the discussion about totally unorthodox therapies vis-a-vis proven protocols, especially in the wake of the death of the creator of Dilbert.

@cxracer, you’re in good hands at Mayo Clinic. Please share your interest in alternate and complementary therapies with the cancer team. Mayo Clinic has an integrative oncology department if you’re interested.

– Integrative Medicine and Health https://www.mayoclinic.org/departments-centers/integrative-medicine-health/sections/overview/ovc-20464567

But, first things first. Here is a list of helpful discussions talking about radical prostatectomy (RP) as you prepare for surgery: https://connect.mayoclinic.org/group/prostate-cancer/

Use the group search to find other useful discussions, including this one on the abbreviations and acronyms you’ll encounter on this journey

- Prostate cancer-related abbreviations: What acronym would you add?
https://connect.mayoclinic.org/discussion/prostate-cancer-related-abbreviations-what-acronym-would-you-add/

@heavyphil I'm taking Ivermectin and Fenbendazole right now and have been since December, I just had a blood test and I will let you know the outcome and if it shows that my PCa markers are down.

@tdoriausername Great…BTW, what is your PSA history thus far? Biopsy?Treatment? Thanks!
Phil

The resistance to anything out of Standard of Care is still very present.
Remember, prostate cancer is a business ..... and a very big one!

Prostate Cancer Market Overview
The prostate cancer market is experiencing significant growth both in the United States and globally. This expansion is fueled by rising incidence rates, advancements in treatment modalities, and increased awareness and diagnostic capabilities. Below is a detailed analysis of the market.

Market Size and Growth Projections
Region Market Size (2026) Projected Size (2034) CAGR (2025-2034)
Global USD 12.88 billion USD 34.28 billion 8.41%
United States USD 16.05 billion USD 28.83 billion 8.50%
Asia Pacific USD 6.21 billion N/A N/A

The global prostate cancer market was valued at approximately USD 12.88 billion in 2025 and is projected to grow to USD 34.28 billion by 2034, with a compound annual growth rate (CAGR) of 8.41%. In the U.S. specifically, the market is similarly expected to grow significantly over the same period.

Key Drivers of Market Growth
Increased Incidence: The average age of diagnosis is around 66 years, with the majority of cases occurring in men aged 50 and older. The global prevalence of prostate cancer is increasing, currently accounting for about 1.4 million new diagnoses annually.
Advancements in Treatment Options: New treatments, including:
Hormonal therapies (e.g., androgen receptor inhibitors).
Immunotherapies and targeted therapies (e.g., PSMA-targeted radioligands).
Growth in biomarker-driven therapies.
Increased Awareness and Screening: Campaigns aimed at raising awareness about prostate cancer have led to more men seeking screening through tests such as PSA and MRI.
Innovations in Diagnostics: Enhanced diagnostic technologies, including multiparametric MRI and biomarker-based diagnostics, are driving market growth by improving detection rates.
Investment in Healthcare Infrastructure: Investments in hospitals and cancer treatment centers, particularly in emerging markets, are improving access to treatment and diagnostic services.

Challenges Facing the Market
Challenge Description
High Treatment Costs Advanced therapies can be prohibitively expensive, especially in developing regions.
Market Disparities There are significant differences in access to treatments across regions and socioeconomic groups, which can limit market expansion.
Regulatory and Reimbursement Issues Varying reimbursement policies can hinder patient access to newly approved therapies.

Competitive Landscape
Key companies leading the prostate cancer therapeutics market include:

Johnson & Johnson Services, Inc.
Astellas Pharma Inc.
Eli Lilly and Company
Merck & Co., Inc.
Pfizer Inc.

These companies are actively engaged in research and development of new therapies and are pursuing collaborations and partnerships to enhance their market share.

Emerging Trends
Online Pharmacies: There is a growing trend toward online pharmacies, which improve access to medications, especially in underserved areas.

Shift to Precision Medicine: There is an increasing focus on personalized treatment approaches, tailoring therapies based on individual genetic markers and response profiles.
Minimally Invasive Treatments: The adoption of robot-assisted surgical techniques and other minimally invasive methodologies is transforming treatment options.

Conclusion
The prostate cancer market is set to evolve significantly over the next decade, led by innovative therapies, expanding access to care, and increasing public awareness. However, addressing the challenges of treatment costs and market disparities will be critical in ensuring comprehensive patient access and improving outcomes worldwide.